D. E. Shaw & Co., Inc. Care Dx, Inc. Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 783,013 shares of CDNA stock, worth $13.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

783,013

Previous 1,149,228 31.87%

Holding current value

$13.9 Million

Previous $24.6 Million 43.51%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$17.64 - $25.07 $6.46 Million - $9.18 Million	-366,215 Reduced 31.87%	783,013 $13.9 Million
Q4 2024 Feb 14, 2025	SELL	$20.4 - $32.2 $4.3 Million - $6.79 Million	-210,999 Reduced 15.51%	1,149,228 $24.6 Million
Q3 2024 Nov 14, 2024	SELL	$14.41 - $33.99 $5.3 Million - $12.5 Million	-367,663 Reduced 21.28%	1,360,227 $42.5 Million
Q2 2024 Aug 14, 2024	SELL	$7.56 - $16.15 $2.22 Million - $4.75 Million	-294,244 Reduced 14.55%	1,727,890 $26.8 Million
Q1 2024 May 15, 2024	SELL	$7.96 - $12.37 $1.43 Million - $2.22 Million	-179,087 Reduced 8.14%	2,022,134 $21.4 Million
Q4 2023 Feb 14, 2024	SELL	$4.9 - $12.86 $603,733 - $1.58 Million	-123,211 Reduced 5.3%	2,201,221 $26.4 Million
Q3 2023 Nov 14, 2023	SELL	$7.0 - $11.26 $779,247 - $1.25 Million	-111,321 Reduced 4.57%	2,324,432 $16.3 Million
Q2 2023 Aug 14, 2023	BUY	$7.61 - $9.46 $3.05 Million - $3.8 Million	401,225 Added 19.72%	2,435,753 $20.7 Million
Q1 2023 May 15, 2023	BUY	$8.83 - $17.61 $5.55 Million - $11.1 Million	628,715 Added 44.72%	2,034,528 $18.6 Million
Q4 2022 Feb 14, 2023	BUY	$10.88 - $20.05 $5.77 Million - $10.6 Million	530,583 Added 60.62%	1,405,813 $16 Million
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $6.26 Million - $10.3 Million	389,618 Added 80.23%	875,230 $14.9 Million
Q2 2022 Aug 15, 2022	BUY	$20.49 - $39.72 $3.36 Million - $6.52 Million	164,129 Added 51.05%	485,612 $10.4 Million
Q1 2022 May 16, 2022	SELL	$28.19 - $46.6 $4.16 Million - $6.88 Million	-147,684 Reduced 31.48%	321,483 $11.9 Million
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $14.3 Million - $25.5 Million	-346,998 Reduced 42.52%	469,167 $21.3 Million
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $5.76 Million - $8.97 Million	-97,462 Reduced 10.67%	816,165 $51.7 Million
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $19.1 Million - $28.8 Million	-302,304 Reduced 24.86%	913,627 $83.6 Million
Q1 2021 May 17, 2021	SELL	$57.62 - $95.6 $697,317 - $1.16 Million	-12,102 Reduced 0.99%	1,215,931 $82.8 Million
Q4 2020 Feb 16, 2021	SELL	$41.43 - $77.09 $2.17 Million - $4.04 Million	-52,398 Reduced 4.09%	1,228,033 $89 Million
Q3 2020 Nov 16, 2020	BUY	$30.88 - $37.94 $13.4 Million - $16.5 Million	435,531 Added 51.55%	1,280,431 $48.6 Million
Q2 2020 Aug 14, 2020	BUY	$18.95 - $35.43 $3.13 Million - $5.86 Million	165,362 Added 24.33%	844,900 $29.9 Million
Q1 2020 May 15, 2020	BUY	$13.94 - $28.25 $2.61 Million - $5.29 Million	187,105 Added 38.0%	679,538 $14.8 Million
Q4 2019 Feb 14, 2020	SELL	$19.24 - $28.41 $1.47 Million - $2.17 Million	-76,267 Reduced 13.41%	492,433 $10.6 Million
Q3 2019 Nov 14, 2019	BUY	$20.03 - $40.08 $1.31 Million - $2.63 Million	65,601 Added 13.04%	568,700 $12.9 Million
Q2 2019 Aug 14, 2019	BUY	$25.78 - $39.77 $9.02 Million - $13.9 Million	349,920 Added 228.44%	503,099 $18.1 Million
Q1 2019 May 15, 2019	SELL	$22.09 - $39.21 $713,440 - $1.27 Million	-32,297 Reduced 17.41%	153,179 $4.83 Million
Q4 2018 Feb 14, 2019	SELL	$19.89 - $30.02 $2.03 Million - $3.06 Million	-101,976 Reduced 35.48%	185,476 $4.66 Million
Q3 2018 Nov 14, 2018	SELL	$12.1 - $28.85 $3.16 Million - $7.54 Million	-261,304 Reduced 47.62%	287,452 $8.29 Million
Q2 2018 Aug 14, 2018	BUY	$7.93 - $15.79 $4.35 Million - $8.66 Million	548,756 New	548,756 $6.72 Million

Others Institutions Holding CDNA

# of Institutions

230

Shares Held

56.8M

Call Options Held

51.2K

Put Options Held

46K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $948M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account